Akiko Kobayashi

Long‐term safety and efficacy of antimuscarinic add‐on therapy in patients with overactive bladder who had a suboptimal response to mirabegron monotherapy: A multicenter, randomized study in Japan (MILAI II study)

Y. Homma, H. Kakizaki, O. Yamaguchi, 2018, International journal of urology : official journal of the Japanese Urological Association.

Safety and efficacy of mirabegron as ‘add‐on’ therapy in patients with overactive bladder treated with solifenacin: a post‐marketing, open‐label study in Japan (MILAI study)

Y. Homma, H. Kakizaki, O. Yamaguchi, 2015, BJU international.

Inhibitory effects of thiol compounds on theaflavin browning and structural analysis of the causative substances.

H. Ono, T. Nakayama, K. Chiku, 2022, Food chemistry.